FDA Warning Letter — AcelRx Pharmaceuticals, Inc.

Case 613257 — FEI 3006386491

The FDA took a Warning Letter action against AcelRx Pharmaceuticals, Inc. on February 11, 2021 (Hayward, CA). The action was issued by CDER and concerns drugs products. This facility has 3 recent FDA inspections on record.

Action Details

Facility
AcelRx Pharmaceuticals, Inc.
Date
February 11, 2021
Fiscal Year
2021
Product Type
Drugs
Center
CDER
Location
Hayward, CA (United States)